UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2026
Commission File Number: 001-42456
INLIF LIMITED
No. 88, Hongsi Road
Yangxi New Area, Honglai Town
Nan’an City, Quanzhou
The People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
As previously disclosed in the Current Report
on Form 6-K furnished by INLIF LIMITED (the “Company”) to the U.S. Securities and Exchange Commission (the “SEC”)
on October 21, 2026, on October 19, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”)
with certain investors (the “Holders”), pursuant to which the Company issued, among other securities, on October 20, 2026
(the “Issuance Date”), Series A warrants (the “Series A Warrants”) and Series B warrants (the “Series B
Warrants”). Each Series B Warrant is exercisable for units (“Units”), each consisting of one Class A ordinary share
of the Company, par value US$0.0001 per share (the “Ordinary Shares”), and one Series A Warrant. The Series B Warrants provided
for a one-time reset of the exercise price upon the completion of a reset period ending on November 17, 2026 (the “Reset Date”),
subject to a floor price of US$0.51 per Unit (the “Floor Price”), with a proportionate increase in the number of Units issuable
thereunder. Upon the completion of the reset period, the exercise price of the Series B Warrants was reset to US$0.51 per Unit.
On November 18, 2026, the Company and the Holders mutually agreed to
amend the reset provisions of the Series B Warrants. Pursuant to such amendment, the initial exercise price of the Series B Warrants remains
unchanged, and in lieu of the reset price of US$0.51 per Unit determined upon the completion of the reset period, and notwithstanding
the Floor Price, the reset price of the Series B Warrants shall be US$0.30 per Unit, with effect as of the Reset Date. Accordingly, the
exercise price of the Series B Warrants has been reduced to US$0.30 per Unit, and the number of Units issuable upon exercise of the Series
B Warrants has been proportionately increased so that the aggregate exercise price payable thereunder, after giving effect to such reduction,
equals the aggregate exercise price on the Issuance Date. As a result, the Series B Warrants are exercisable for an aggregate of 12,500,001
Units (previously 7,352,943 Units).
The Company and the Holders further agreed that any Series A Warrants
issued upon exercise of the Series B Warrants following such amendment shall have an exercise price of US$0.30 per Ordinary Share. In
addition, the Series A Warrants issued on the Issuance Date have been amended in the same manner, such that their reset price is US$0.30
per Ordinary Share, notwithstanding the floor price applicable thereto, with a proportionate increase in the number of Ordinary Shares
issuable thereunder, so that all Series A Warrants carry consistent terms.
The expiration date of the Series B Warrants (December 21, 2026) and
all other terms and conditions of the Series B Warrants and the Series A Warrants remain unchanged and in full force and effect.
This Report on Form 6-K shall not constitute an offer to sell or the
solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
This Report, including the exhibits included hereto,
shall be incorporated by reference into: (i) the Company’s shelf registration statement on Form F-3, as amended (File No. 333-292580)
(the “Registration Statement”), which Registration Statement was declared effective by the SEC on January 12, 2026,
and (ii) the Company’s registration statement on Form S-8 (File No. 333-289640), which was filed with the SEC on August 15, 2025,
and into each prospectus or prospectus supplement outstanding under the Registration Statement, to the extent not superseded by documents
or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act
of 1934, as amended.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: November 18, 2026
| |
INLIF LIMITED |
| |
|
|
| |
By: |
/s/ Rongjun Xu |
| |
Name: |
Rongjun Xu |
| |
Title: |
Chief Executive Officer |